-
Analyst Opinions
Tech, Genes, and Beyond – Startup Transforming Biotech
Biotech Startups Overview Biotech breakthroughs drive cost savings, provide competitive advantages, and showcase efficiency across industries through streamlined manufacturing, custom product development, and resilient supply chains. Biotech advancements are also reshaping the fields of medicine, agriculture, and industry. Startups are leading the way for biotechnology advancements, driven by healthcare demands, government support, and technological breakthroughs. Furthermore, AI integration is driving progress in DNA sequencing, drug discovery, and precision medicine. Meanwhile, ambitious projects such as longevity research and brain-computer interface implants...
-
Product Insights
Clinical Chemistry Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Clinical Chemistry Pipeline Market Report Overview Clinical Chemistry comprises reagents, test kits, and electrodes. This assists in determining the concentration or activity of biomolecules, such as proteins, carbohydrates, lipids, enzymes, minerals, or other small molecules. The Clinical Chemistry pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by...
-
Company Profile
Vietnam Dairy Products Joint Stock Co – Company Profile
Vietnam Dairy Products Joint Stock Co (Vinamilk) produces, markets, and distributes milk and other dairy products. The company's product portfolio includes fresh milk, yogurt, powder milk, nutrition products for adults, infant cereals, condensed milk, beverages, ice cream, cheese and soymilk. It distributes non-alcoholic beverages that comprise fruit juice, aloe vera drink, bottled drinking water, salted lemonade, and tea. The company markets these products under the Vinamilk, Longevity sweetened condensed milk, Southern Star Dielac, Kenko, Delight, and Vfresh Fruit Juice brand...
Add to Basket -
Product Insights
Upstate Medical – Nappi Longevity Institute – New York
Equip yourself with the essential tools needed to make informed and profitable decisions with our Upstate Medical - Nappi Longevity Institute - New York report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Product Insights
Longevity Prop – 6979 Yonge Mixed-Use Condominium Building – Ontario
Equip yourself with the essential tools needed to make informed and profitable decisions with our Longevity Prop - 6979 Yonge Mixed-Use Condominium Building - Ontario report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Company Profile
CohBar Inc – Company Profile
CohBar Inc (CohBar) is a developer of mitochondria-based therapeutics. It develops a class of drugs to treat a wide range of diseases associated with aging and metabolic dysfunction such as non-alcoholic steatohepatitis, obesity, cancer and others. The company offers MDP drugs such as CB4211 for the treatment of NASH and obesity and CB5138-3 for the treatment of fibrotic disease. CohBar’s expertise comprises cellular and mitochondrial genetics and biology, metabolism, the biology of aging, drug discovery, development and commercialization. The company...
Add to Basket -
Product Insights
Hip Reconstruction – Zimmer Biomet Holdings Inc – LONGEVITY
GlobalData, the industry analysis specialist, has released its latest report: Hip Reconstruction - Zimmer Biomet Holdings Inc - LONGEVITY. The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. In addition, the final selling pricing of medical devices is also impacted by...
-
Product Insights
Hip Reconstruction – Zimmer Biomet Holdings Inc – ZCA LONGEVITY
GlobalData, the industry analysis specialist, has released its latest report: Hip Reconstruction - Zimmer Biomet Holdings Inc - ZCA LONGEVITY. The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. In addition, the final selling pricing of medical devices is also impacted...
-
Product Insights
Hip Reconstruction – Zimmer Biomet Holdings Inc – TRILOGY LONGEVITY
GlobalData, the industry analysis specialist, has released its latest report: Hip Reconstruction - Zimmer Biomet Holdings Inc - TRILOGY LONGEVITY. The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. In addition, the final selling pricing of medical devices is also impacted...
-
Product Insights
Hip Reconstruction – Zimmer Biomet Holdings Inc – HGP LONGEVITY
GlobalData, the industry analysis specialist, has released its latest report: Hip Reconstruction - Zimmer Biomet Holdings Inc - HGP LONGEVITY. The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. In addition, the final selling pricing of medical devices is also impacted...